<DOC>
	<DOCNO>NCT00804284</DOCNO>
	<brief_summary>The objective study characterize safety profile PENTACEL® vaccine identification potential vaccine-related adverse event currently associate PENTACEL® vaccine administration .</brief_summary>
	<brief_title>Database Surveillance Safety Study PENTACEL® Vaccine</brief_title>
	<detailed_description>The study conduct Kaiser Permanente Northern California commence first use licensed PENTACEL® vaccine within organization . Vaccination databases review identify Diphtheria tetanus toxoid acellular pertussis ( DTaP ) vaccination accrue subject . Medical encounter , emergency room , hospitalization , laboratory , state death reporting , related database review identify medical care event .</detailed_description>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Tetany</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Receipt DTaP vaccine study period previously unvaccinated child</criteria>
	<gender>Male</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>DAPTACEL®</keyword>
	<keyword>PENTACEL®</keyword>
	<keyword>Diphtheria</keyword>
	<keyword>Tetanus</keyword>
	<keyword>Pertussis</keyword>
	<keyword>Haemophilus influenzae type b</keyword>
</DOC>